STOCK TITAN

AYR Wellness Provides Update on Q1 2025 Interim Filings

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

AYR Wellness (OTCQX: AYRWF), a vertically integrated U.S. multi-state cannabis operator, announced delays in filing its Q1 2025 interim financial statements and related documents. The delay is attributed to ongoing negotiations with creditors and assessment of debt obligation classifications with senior lenders.

The company is currently under a failure-to-file cease-trade order (FFCTO) issued by the Ontario Securities Commission, which prohibits trading of AYR's securities in Canadian jurisdictions and has resulted in a trading suspension on the Canadian Securities Exchange. AYR is conducting a broader strategic review to address upcoming payment obligations and support its long-term strategic plan.

AYR Wellness (OTCQX: AYRWF), operatore statunitense integrato verticalmente nel settore della cannabis con attività in più stati, ha annunciato ritardi nella presentazione dei bilanci finanziari intermedi del primo trimestre 2025 e dei documenti correlati. Il ritardo è dovuto a negoziazioni in corso con i creditori e alla valutazione della classificazione degli obblighi debitori con i principali finanziatori.

L'azienda è attualmente soggetta a un ordine di sospensione del commercio per mancata presentazione (FFCTO) emesso dalla Ontario Securities Commission, che vieta la negoziazione dei titoli AYR nelle giurisdizioni canadesi e ha causato la sospensione delle negoziazioni sulla Canadian Securities Exchange. AYR sta conducendo una revisione strategica più ampia per affrontare gli obblighi di pagamento imminenti e sostenere il suo piano strategico a lungo termine.

AYR Wellness (OTCQX: AYRWF), operador estadounidense de cannabis integrado verticalmente y presente en varios estados, anunció retrasos en la presentación de sus estados financieros interinos del primer trimestre de 2025 y documentos relacionados. El retraso se atribuye a negociaciones en curso con los acreedores y a la evaluación de la clasificación de las obligaciones de deuda con los prestamistas principales.

La compañía se encuentra actualmente bajo una orden de suspensión de comercio por incumplimiento de presentación (FFCTO) emitida por la Ontario Securities Commission, que prohíbe la negociación de los valores de AYR en jurisdicciones canadienses y ha provocado la suspensión de la negociación en la Canadian Securities Exchange. AYR está llevando a cabo una revisión estratégica más amplia para abordar las obligaciones de pago próximas y apoyar su plan estratégico a largo plazo.

AYR Wellness (OTCQX: AYRWF)는 미국 내 다수 주에서 수직 통합된 대마초 운영업체로서 2025년 1분기 중간 재무제표 및 관련 서류 제출이 지연되고 있음을 발표했습니다. 이 지연은 채권자들과의 진행 중인 협상 및 주요 대출기관과의 부채 의무 분류 평가 때문입니다.

회사는 현재 온타리오 증권위원회가 발행한 미제출로 인한 거래정지 명령(FFCTO) 하에 있어, 캐나다 관할 지역에서 AYR 증권 거래가 금지되었으며 캐나다 증권거래소에서 거래가 중단된 상태입니다. AYR는 다가오는 지불 의무를 해결하고 장기 전략 계획을 지원하기 위해 보다 광범위한 전략 검토를 진행 중입니다.

AYR Wellness (OTCQX : AYRWF), opérateur américain intégré verticalement dans plusieurs États du secteur du cannabis, a annoncé des retards dans le dépôt de ses états financiers intermédiaires du premier trimestre 2025 et des documents associés. Ce retard est attribué à des négociations en cours avec les créanciers et à l’évaluation des classifications des obligations de dette avec les prêteurs principaux.

L’entreprise est actuellement soumise à un ordre de suspension de négociation pour défaut de dépôt (FFCTO) émis par la Commission des valeurs mobilières de l’Ontario, qui interdit la négociation des titres d’AYR dans les juridictions canadiennes et a entraîné une suspension des échanges à la Bourse des valeurs canadienne. AYR mène une revue stratégique plus large pour faire face aux obligations de paiement à venir et soutenir son plan stratégique à long terme.

AYR Wellness (OTCQX: AYRWF), ein vertikal integrierter US-Multi-State-Cannabisbetreiber, gab Verzögerungen bei der Einreichung der vorläufigen Finanzberichte für das erste Quartal 2025 und der dazugehörigen Dokumente bekannt. Die Verzögerung ist auf laufende Verhandlungen mit Gläubigern und die Bewertung der Klassifizierung von Schuldenverpflichtungen mit den Senior-Kreditgebern zurückzuführen.

Das Unternehmen befindet sich derzeit unter einer Handelsaussetzung wegen Nicht-Einreichung (FFCTO), die von der Ontario Securities Commission verhängt wurde. Diese verbietet den Handel mit AYR-Wertpapieren in kanadischen Rechtsgebieten und hat zu einem Handelsstopp an der Canadian Securities Exchange geführt. AYR führt eine umfassendere strategische Überprüfung durch, um bevorstehende Zahlungsverpflichtungen zu bewältigen und seinen langfristigen strategischen Plan zu unterstützen.

Positive
  • None.
Negative
  • Company unable to file Q1 2025 interim financial statements on time
  • Failure-to-file cease-trade order (FFCTO) in effect, prohibiting trading of securities in Canada
  • Ongoing negotiations with creditors regarding debt obligations indicate potential financial distress
  • No precise timeline provided for completion of interim filings

MIAMI, June 27, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, provides an update regarding the status of its interim financial statements, management’s discussion and analysis, and related CEO and CFO certificates for the three-month period ended March 31, 2025 (collectively, the “Interim Filings”).‎

As previously disclosed, the Company’s delay in completing the Interim Filings is primarily due to ongoing negotiations with its creditors and the continued assessment of the appropriate accounting classifications of certain debt obligations currently under negotiation with a committee of its senior lenders. These negotiations form part of a broader strategic review process as the Company evaluates capital structure alternatives and other strategic options to address its upcoming payment obligations and support the execution of its long-term strategic plan.

At this time, AYR does not have a precise estimate as to when the Interim Filings will be completed and filed. The Company is working diligently to resolve the outstanding matters and will provide further updates as and when appropriate.

The failure-to-file cease-trade order (“FFCTO”) issued by the Ontario Securities Commission remains in effect, prohibiting all trading in AYR’s securities in all Canadian jurisdictions and resulting in a suspension of the Company’s securities from trading on the Canadian Securities Exchange. The FFCTO will remain in place until the Interim Filings are completed and all applicable requirements are satisfied.

Forward-Looking Statements
Certain statements contained in this news release may contain forward-looking information or may be forward-looking statements (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking statements are often, but not always, identified by the use of words such as "target," "expect," "anticipate," "believe," "foresee," "could," "would," "estimate," "goal," "outlook," "intend," "plan," "seek," "will," "may," "tracking," "pacing," and "should" and similar expressions or words suggesting future outcomes. This news release includes forward-looking statements pertaining to, among other things, the timing and completion of the Interim Filings, the outcome of ongoing negotiations with the ad hoc committee of the Company’s senior lenders, the impact of the FFCTO, and the Company's strategic review process. Numerous risks and uncertainties could cause actual events and results to differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those anticipated. AYR undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

About AYR Wellness Inc.
AYR Wellness is a vertically integrated, U.S. multi-state cannabis business. The Company operates simultaneously as a retailer with 90+ licensed dispensaries and a house of cannabis CPG brands.

AYR is committed to delivering high-quality cannabis products to its patients and customers while acting as a Force for Good for its team members and the communities that the Company serves. For more information, please visit www.ayrwellness.com.

Company/Media Contact:
Robert Vanisko
SVP, Public Affairs
T: (786) 885-0397
Email: comms@ayrwellness.com

Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
T: (786) 885-0397


FAQ

Why is AYR Wellness (AYRWF) stock suspended from trading in Canada?

AYR Wellness is under a failure-to-file cease-trade order (FFCTO) from the Ontario Securities Commission due to delayed Q1 2025 interim financial filings, resulting in trading suspension on the Canadian Securities Exchange.

What is causing the delay in AYR Wellness Q1 2025 financial filings?

The delay is primarily due to ongoing negotiations with creditors and the assessment of accounting classifications for certain debt obligations being negotiated with senior lenders.

When will AYR Wellness (AYRWF) resume trading in Canada?

Trading will resume once the company completes its Q1 2025 interim filings and satisfies all applicable requirements under the failure-to-file cease-trade order (FFCTO). No specific timeline has been provided.

What strategic actions is AYR Wellness taking to address its financial situation?

AYR is conducting a strategic review process to evaluate capital structure alternatives and strategic options to address upcoming payment obligations and support its long-term strategic plan.

How does the FFCTO affect AYR Wellness shareholders?

The FFCTO prohibits all trading of AYR's securities in Canadian jurisdictions and has resulted in a suspension from trading on the Canadian Securities Exchange, limiting shareholders' ability to trade their shares in Canada.
Ayr Wellness Inc.

OTC:AYRWF

AYRWF Rankings

AYRWF Latest News

AYRWF Stock Data

19.99M
59.63M
14.33%
16.25%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Miami